188 related articles for article (PubMed ID: 23436584)
1. Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.
Goenka A; Morris LG; Rao SS; Wolden SL; Wong RJ; Kraus DH; Ohri N; Setton J; Lok BH; Riaz N; Mychalczak BR; Schoder H; Ganly I; Shah JP; Pfister DG; Zelefsky MJ; Lee NY
Int J Cancer; 2013 Sep; 133(5):1214-21. PubMed ID: 23436584
[TBL] [Abstract][Full Text] [Related]
2. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
Bird T; Barrington S; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1239-47. PubMed ID: 26707387
[TBL] [Abstract][Full Text] [Related]
4. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
[TBL] [Abstract][Full Text] [Related]
5. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
6. CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Rosen BS; Wilkie JR; Sun Y; Ibrahim M; Casper KA; Miller JE; Chotchutipan T; Stucken CL; Bradford C; Prince MEP; Rosko AJ; Malloy KM; McLean SA; Chinn SB; Shuman AG; Spector ME; Swiecicki PL; Worden FP; Shah JL; Schonewolf CA; Chapman CH; Eisbruch A; Mierzwa ML
Radiother Oncol; 2021 Feb; 155():174-181. PubMed ID: 33069764
[TBL] [Abstract][Full Text] [Related]
7. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
[TBL] [Abstract][Full Text] [Related]
9. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
[TBL] [Abstract][Full Text] [Related]
11. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H
J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812
[TBL] [Abstract][Full Text] [Related]
13. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
Clavel S; Charron MP; Bélair M; Delouya G; Fortin B; Després P; Soulières D; Filion E; Guertin L; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):567-73. PubMed ID: 21310545
[TBL] [Abstract][Full Text] [Related]
14. Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Lee J; Davis SJ; Amin SN; Rohde SL; Kim YJ
Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1133-1139. PubMed ID: 36453776
[TBL] [Abstract][Full Text] [Related]
15. Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Zhou S; Chan C; Rulach R; Dyab H; Hendry F; Maxfield C; Dempsey MF; James A; Grose D; Lamb C; Schipani S; Wilson C; Cheng Lau Y; Paterson C
Oral Oncol; 2022 May; 128():105870. PubMed ID: 35447564
[TBL] [Abstract][Full Text] [Related]
16. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
[TBL] [Abstract][Full Text] [Related]
17. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M
Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346
[TBL] [Abstract][Full Text] [Related]
18. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
[TBL] [Abstract][Full Text] [Related]
19. Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.
Vainshtein JM; Spector ME; Stenmark MH; Bradford CR; Wolf GT; Worden FP; Chepeha DB; McHugh JB; Carey T; Wong KK; Eisbruch A
Oral Oncol; 2014 Mar; 50(3):234-9. PubMed ID: 24387978
[TBL] [Abstract][Full Text] [Related]
20. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Mehanna H; Wong WL; McConkey CC; Rahman JK; Robinson M; Hartley AG; Nutting C; Powell N; Al-Booz H; Robinson M; Junor E; Rizwanullah M; von Zeidler SV; Wieshmann H; Hulme C; Smith AF; Hall P; Dunn J;
N Engl J Med; 2016 Apr; 374(15):1444-54. PubMed ID: 27007578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
